T1124 Once Daily 3g Mesalamine Is the Optimal Dose for Maintaining Clinical Remission in Ulcerative Colitis: A Double-Blind, Double-Dummy, Randomized, Controlled, Dose-Ranging Study

Kruis, Wolfgang; Jonaitis, Laimas Virginijus; Pokrotnieks, Juris; Acutė, Gitana; Михайлова, Т. Л.; Horyński, M.; Bátovský, M; Rácz, I; Kull, Karin; Faszczyk, Mark

doi:10.1016/s0016-5085(08)62285-4

T1124 Once Daily 3g Mesalamine Is the Optimal Dose for Maintaining Clinical Remission in Ulcerative Colitis: A Double-Blind, Double-Dummy, Randomized, Controlled, Dose-Ranging Study

NobleIDNI7P74W75R09S57

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2D85DDF7.svg?ark=w1%2F20260521%2F2D85DDF7&value=id)](https://nobleid.org/work/w1/20260521/2D85DDF7)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Wolfgang Kruis

Laimas Virginijus Jonaitis

Claim authorship of this work

T1124 Once Daily 3g Mesalamine Is the Optimal Dose for Maintaining Clinical Remission in Ulcerative Colitis: A Double-Blind, Double-Dummy, Randomized, Controlled, Dose-Ranging Study

NobleIDNI7P74W75R09S57

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2D85DDF7.svg?ark=w1%2F20260521%2F2D85DDF7&value=id)](https://nobleid.org/work/w1/20260521/2D85DDF7)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Wolfgang Kruis

Laimas Virginijus Jonaitis

Claim authorship of this work